4Reliance and the Inovet Group (Belgium), a family owned veterinary pharmaceuticals group, have a long-standing business relation dating back to 2007, when assisting the company with the acquisition of Laboratoires Biové (France). Since this successful acquisition, 4Reliance has been the strategic advisor of the Group assisting in the strategic positioning of the Group, its growth program and the corporate debt structuring of the Group.
In 2019, 4Reliance advised Inovet on the acquisition of all licenses and production rights held by Alvetra & Werfft GmbH (the veterinary division of the in Austria listed Sanochemia) as well as on a 19M€ debt & subsidy financing of a new manufacturing site for injectables. In 2022, 4Reliance advised the founder on the sale of the company to Orion Corporation – a globally operating Finnish pharmaceutical company.

Weerts Real Estate Investment Management (“WREIM”) is a dedicated entity that provides development and management services for the real estate activities of Weerts Group.
4Reliance advised Weerts Group on the raising of €40m growth capital from Kartesia.

Barré is a provider of state-of-the-art engineering solutions for pharmaceutical manufacturing sites.
4Reliance advised in 2019 the founder on the trade sale of the company in the context of a management buy in transaction.

The Barracuda Company is a leading Belgian e-bike retail group.
4Reliance advised the shareholders of the company on the sale of a majority stake to Profinpar

Group VHC is a Belgian leader in the field of air conditioning, ventilation, heating.
4Reliance advised the founder on the sale of the company in the context of a management buy in transaction.

GeoTherma and its sister company Jordaan Energy Systems are active in the distribution and installation of heat pumps and related thermal concepts.
4Reliance advised the founders on the sale of the company to the private equity fund Tilleghem.

ACE electronics is a Belgian headquartered developer and manufacturer of high-end electronic applications for a broad range of business sectors.
In 2018, 4Reliance advised on the management buy-out of the company and acts as strategic adviser along with the new management. In 2022, 4Reliance advised the shareholder of the company on the sale of a majority stake to Alliance Electronics SAS, an international consortium of Electronics Manufacturing Services (EMS) companies backed by Waterland Private Equity.

Conteno is a provider of innovative PET bottling systems allowing more sustainable and integrated solutions anywhere in the world.
4Reliance advised on the acquisition of a minority stake in the capital and has supported the company in the closing of a major commercial agreement signed in 2019.

Pairi Daiza is one of the leading zoological park in the Benelux with a strong commitment in the preservation of endangered species.
4Reliance has served Pairi Daiza as Listing Sponsor on Euronext Brussels.

4Reliance advised CDM (Belgium), the reference in high-end noise & vibration isolation solutions, in the sale of its track-division to Pandrol (Delachaux Group-France) in a mixed share-and asset-deal. Undisclosed amount.

4Reliance is a long-standing business partner of Ecophos (Belgium), a world-leading business solution provider to the phosphate industry, assisting the company and its shareholder in strategic positioning and corporate advice.

4Reliance advised the shareholders of Etablissements Eugène Dirckx (Ed-Dis Lighting Solutions – Belgium) in the trade sale
to Performance-In-Lighting Group (Italy).

4Reliance advised the shareholders of Busker Groep (Netherlands), active in a specialised niche of the construction market, in the sale to NIBC Private Equity (Netherlands).

4Reliance was involved in the history of Agripalma (Belgium – Sao-Tomé) from its incorporation, its ambitious growth in agricultural development, to its trade sale. 4Reliance assisted the majority shareholders of Agripalma in the sale to stock-listed Socfin Group (Luxemburg).

4Reliance assisted Aveve management team in market research and the analysis of different acquisition targets.